HOWARD C BIRNDORF
CIK 1078432 · Executive Chairman and CEO · last filed 2022-11-16
HOWARD C BIRNDORF is an Executive Chairman and CEO who has filed 4 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ADMP, was dated Nov 16, 2022.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMK PHARMACEUTICALS Corp (ADMP) Delisted | Director | — | $0.78 | — | $0 | 2 | 2022-11-16 |
| NGEN | Executive Chairman and CEO | — | $1.92 | — | $0 | 2 | 2008-04-23 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-16 | DMK PHARMACEUTICALS Corp (ADMP) Delisted | Mixed | — | $0 | EDGAR |
| 2019-10-10 | DMK PHARMACEUTICALS Corp (ADMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-04-23 | NGEN | Grant (A) | — | $0 | EDGAR |
| 2007-06-15 | NGEN | Grant (A) | — | $0 | EDGAR |